Navigation Links
Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3
Date:11/14/2007

VANCOUVER, Nov. 14 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG; BBSE: DRP) today announced its financial results for the three and nine months ended September 30, 2007, showing strong growth in sales and profits for its core antibiotic business. Meanwhile, the Company also announced the sale of its EPO operation to an unaffiliated party through a separate press release.

Highlights for the three and nine months ended September 30, 2007

-----------------------------------------------------------------

- Sales for the third quarter increased 102% to $23.10 million from

$11.41 million for the same period of 2006. Sales for the first nine

months reached $59.98 million, with an increase of 60% as compared to

the same period of 2006;

- Gross profit and gross margin for the third quarter were

$4.31 million and 18.66% compared to $0.73 million and 6.38% for the

same period of 2006;

- Operating income increased 347% to $1.31 million for this quarter

from a net loss of $0.53 million for same period of 2006;

- Net cash inflow generated from operating activities for the quarter

was $2.08 million, as compared to a net cash outflow of $1.23 million

for same period of 2006;

- Net income from continuing operations for the third quarter amounted

to $0.97 million, up 200% from a net loss of $0.97 million for the

same period of 2006;

- A net loss of $2.57 million was shown from discontinuing operations,

which was due to the impact of a $2.64 million non-cash impairment

charge of intangible assets and goodwill related to EPO disposal.

As the result of the EPO disposal, the Company will be focusing on core antibiotic business with vertical product lines covering intermediates, active pharmaceutical ingredients and formulation drugs, which all grew strongly over
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
2. CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path
3. Akela Pharma Inc. Completes Share Consolidation
4. Cosmetic Bootcamp Solidifies Lead as Investor Symposium for Aesthetic Medicine
5. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
6. Nurses From Across Nation Join Solidarity Caravan in Support of Striking Kentucky RNs
7. Smoking may strongly increase long-term risk of eye disease
8. Diabetes appears to increase risk of death for patients with acute coronary syndromes
9. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
10. Fat on chest and upper back increases risk of insulin resistance
11. Ability to cope with stress can increase good cholesterol in older white men, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 Puritan Medical Products, ... the medical, diagnostic, environmental, and forensics industries celebrates ... products in the US. At a time when ... the US, Puritan remains committed to designing and ... Guilford, Maine facility. , Since 1919, Puritan has ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Yisrayl Hawkins, Pastor ... has released a new letter calling on religious leaders to ... letter, which was published on his blog, discusses the history ... is needed to stop it. Yisrayl says mankind was created ... is experienced in today’s society. , “Yahweh created mankind, ...
(Date:5/22/2015)... Viejo, CA (PRWEB) May 22, 2015 ... editable lower thirds designed exclusively for Final Cut Pro ... compatible with any design. , Intuitive on-screen-controls allow ... unique lower third. Reflections, colors, layouts, and much more ... Inspector window. , Pro3rd Impression comes ...
(Date:5/21/2015)... 2015 World Patent Marketing, a vertically ... Troll Motor Guide, a boat patent that aims to ... recreational boating industry has reached an annual revenue of ... Director of World Patent Marketing , "Americans are ... continued steady growth of seven percent in new sales ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 WellCare Health Plans, ... has been selected by the Florida Healthy Kids Corporation (FHKC) ... years of age, as part of the Florida Healthy Kids ... Oct. 1, 2015, and may be extended for two additional ... to serve children in the FHK program who live in ...
Breaking Medicine News(10 mins):Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2
... Higher levels of C-reactive protein, induced by periodontal ... according to US researchers.,Previous research has suggested that ... liver to release increased levels of C-reactive protein ... but a definite link between the two has ...
... likelier to develop a serious intestinal disorder if ... US scientists., ,A research team from Lousiana University ... a condition that affects about 1 in 400 newborns ... surgery in infants. ,Using the Regenstrief Medical ...
... disease are using one or more type of complementary and ... at Johns Hopkins University in the US have carried out ... Forty per cent use one or more forms of CAM ... ones. There's no link between severity of disease and use ...
... ,Consumption of milk as a child and during ... women, say researchers.,Norwegian investigators have found that childhood ... of breast cancer before the menopause.Dr Annette Hjartaker ... 48,844 premenopausal Norwegian women. Participants were asked to ...
... the main ingredient in the -- depo medroxyprogesterone acetate or ... term. The younger you are when you begin using this ... life. // ,From the time we ... constantly breaking down and re-building, usually in a well-balanced design ...
... have looked at the use of complementary and alternative medicine ... of 20 therapies - from acupuncture to yoga - has ... that complementary and alternative medicine has always been popular, although ... // ,The greatest increase in popularity ...
Cached Medicine News:
(Date:5/22/2015)... 22, 2015 Today, Rhodes Pharmaceuticals L.P. announced ... stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder ... 2015. The announcement comes just ... the U.S. Food and Drug Administration (FDA). ... of methylphenidate capsule with an onset of effect ...
(Date:5/22/2015)... Richmond Pharmacology is a ... a worldwide reputation for excellence in clinical trials. ... peer reviewed medical journals. Its officers are engaged ... discussions about rules for transparency and publication of ... , Clinical research is conducted worldwide, ...
(Date:5/22/2015)...  China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ... in China based on the ... of Mr. Fuxiang Zhang as the Company,s ... Rebecca Yingnan Zhang has been appointed as ... effective immediately. Meanwhile, Ms. Zhang resigned from the position ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3
... 6, 2012  Mylan Inc. (Nasdaq: MYL ) ... of two dermatological products from Valeant Pharmaceuticals. Mylan has ... Phosphate / Benzoyl Peroxide Gel, which is the generic ... manufactured and marketed the generic version of this product ...
... welcomes Michael Podany as Vice President of Sales, West USA ... Mr. Podany will be responsible for developing and managing sales ... Keith (GM, Director of Sales, USA). Mr. ... in creating, managing, and growing a new base of business ...
Cached Medicine Technology:Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 2Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 3Samsung Medison America Appoints Michael Podany as Vice President of Sales, West USA 2
Bipolar Atrial "J" Lead...
Unipolar Atrial "J" Lead...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: